pharmaglobenews

pharmaglobenews

Focal Segmental Glomerulosclerosis Market Size (7MM) was ~USD 734 million in 2022, and It is projected to grow by 2034, estimated DelveInsight

DelveInsight’s “Focal Segmental Glomerulosclerosis Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Focal Segmental Glomerulosclerosis, historical and forecasted epidemiology and the FSGS market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United
29 January 2026

Cannabinoid Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s, “Cannabinoid Pipeline Insight, 2025” report provides comprehensive insights about 40+ companies and 50+ pipeline drugs in Cannabinoid pipeline landscape. It covers the Cannabinoid pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cannabinoid pipeline therapeutics assessment by
22 January 2026

PH-ILD Market Size in the 7MM was ~USD 3 Billion in 2024 and is projected to increase by 2034, estimates DelveInsight

DelveInsight’s “Pulmonary Hypertension associated with Interstitial Lung Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Pulmonary Hypertension associated with Interstitial Lung Disease, historical and forecasted epidemiology, as well as the Pulmonary Hypertension associated with Interstitial Lung Disease
22 January 2026

Structural Heart Devices Market Poised for Significant Growth, Projected to Reach ~USD 25 Billion by 2032 Driven by Increasing Adoption of Minimally Invasive Therapies | DelveInsight

DelveInsight’s Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Structural Heart Devices Market Drivers, barriers, trends, and key market Structural Heart Devices companies in the market. To
22 January 2026

Global Embolic Protection Devices Market Poised for Robust Expansion, Projected to Grow at a CAGR of ~8% Through 2032 | DelveInsight

DelveInsight’s Embolic Protection Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Embolic Protection Devices Companies market shares, challenges, Embolic Protection Devices Market Drivers, barriers, trends, and key market Embolic Protection Devices companies in the market. To
22 January 2026

Erectile Dysfunction Devices Market Poised for Robust Growth, Expected to Expand at ~8% CAGR Through 2032 Driven by Increasing Global Demand and Technological Innovation | DelveInsight

DelveInsight’s Erectile Dysfunction Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Erectile Dysfunction Devices Companies market shares, challenges, Erectile Dysfunction Devices Market Drivers, barriers, trends, and key market Erectile Dysfunction Devices companies in the market. To
22 January 2026
Chronic Refractory Cough Market

Chronic Refractory Cough Market Hits $8.5B in 2024!

The chronic refractory cough (CRC) market is projected to witness substantial growth through 2034, driven by an expanding diagnosed patient population, increasing recognition of chronic cough as a distinct clinical condition, and the shortcomings of currently used off-label therapies. Chronic Refractory Cough
21 January 2026